Christall Technologies
Christall is focused on flavonoid based therapeutic agents. Read below to learn more about our vision and purpose.
Who We Are
We are comprised of biotech innovators, global business leaders, medical doctors and manufacturing experts. Together, we seek to address come of the major health care challenges that confront us.
Principal Leadership:
Dr. Edwin Harris (CEO)- Dr. Harris is a long time bay area biotech veteran and is the inventor of V-Shield, Resgel and Betagen technologies. He developed novel diabetes management technologies while a graduate student at both San Jose State and Stanford Universities, and worked for both IDEC pharmaceuticals and NASA-Ames research center as an immunologist before transitioning to global business and societal leadership. He earned his B.S. in Biological Sciences from the University of California at Davis and his Global Executive Ed.D. from the University of Southern California.
What We Do
Christall technologies develops a variety of therapies including anti-virals, adjuvants, cancer chemotherapies, and diabetes therapies. Our objective is to maximize efficacy while minimizing toxicity in our treatment regimens. We also seek to speed time to market while also implementing advanced manufacturing techniques that can reduce production costs making our therapies more accessible.
Christall Technologies has more therapies in our pipeline which can enhance the effectiveness of vaccines. Our V-Shield product is slated to be available in early 2021, Betagen in early 2022 and Resgel late 2022.
Discover with Us
Christall is always looking for bright and enthusiastic researchers! We have a dynamic team that is diverse and global. Leveraging a variety of CROs, we employ a hybrid model of internal and external lab work.
Open Positions
Sales & Marketing
Getting our product into hospitals for treatment is essential to our success. Help us build our future sales team!
Analytics
It takes bright minds to optimize our strategy for maximum effectiveness. Help guide us on our path to success.